Drug Profile
Terbinafine topical - Celtic Pharma
Alternative Names: IDEA-067; TDT-067; Terbinafine cutaneous suspensionLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator IDEA
- Developer Celtic Pharma
- Class Amines; Antifungals; Carrier proteins; Naphthalenes; Skin disorder therapies; Small molecules
- Mechanism of Action Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Onychomycosis
Most Recent Events
- 11 May 2015 No recent reports on development identified - Phase-III for Onychomycosis in USA, Iceland and Germany (Topical)
- 30 Jun 2012 Celtic Pharma completes a phase II trial for Onychomycosis in USA (NCT01790165)
- 13 Jan 2012 Celtic Pharma completes a phase III trial in Onychomycosis in USA, Germany & Iceland (NCT01145807)